MPOX Vaccination Resoures
Jump to Topic:
- Clinical Guidance and Recommendations
- JYNNEOS (Smallpox/mpox) Vaccine Information
- Intradermal Vaccination Resources
- Other Vaccine Administration Resources
- Vaccine Management and Reporting
- Vaccine and Adverse Reactions Information
- Mpox Disease Information and Educational Resources
- Other Resources
- Archived Communications
Clinical Guidance and Recommendations
- CDPH JYNNEOS mpox vaccine, administration and dosing
- CDPH mpox FAQs for Providers & LHDs
- CDC mpox and Smallpox Vaccine Guidance
- Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. mpox Outbreak (CDC)
- CDPH mpox Vaccine Page
- CDPH mpox Vaccine Prioritization Guidance
- CDPH Considerations for Expanded mpox Post-Exposure Prophylaxis (PEP++)
- MMWR: Use of JYNNEOS for Pre-exposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices, U.S., 2022
- MMWR: Interim Guidance for Prevention and Treatment of mpox in Persons with HIV Infection — United States, August 2022
JYNNEOS (Smallpox/Mpox) Vaccine Information
JYNNEOS is FDA-approved for use in adults 18 years and older as a two-dose series, administered subcutaneously. On 8/9/22, FDA granted Emergency Use Authorization as a two-dose series for the following uses:
· Use in children under 18 years of age, administered subcutaneously
· Use in adults 18 years and older, administered intradermally.
- JYNNEOS Vaccine Fact Sheet | Provider Letter
- Screening Checklist for JYNNEOS Mpox Vaccination | Spanish
- Mpox Vaccination Registration & Consent Form (adults/minors) | Spanish
- JYNNEOS Vaccine Information Statement (VIS) | Spanish (distribute to recipient prior to vaccination)
- JYNNEOS Package Insert (6/2021)
- JYNNEOS EUA Fact Sheet for Providers (8/2022)
- JYNNEOS EUA Fact Sheet for Recipients and Caregivers (8/2022)
Intradermal Vaccination Resources
- JYNNEOS Intradermal Administration job aid (CDC)
- JYNNEOS Intradermal Administration video (CDC)
- JYNNEOS Preparation and Administration Summary for Intradermal Administration (CDC)
- JYNNEOS Standing Orders for Intradermal Administration (CDC)
- JYNNEOS Intradermal Vaccination: Patient Counseling (CDC)
- JYNNEOS Intradermal Vaccination Considerations for Specific Populations (CDC)
- JYNNEOS EUA Fact Sheet for Providers (8/2022)
- JYNNEOS EUA Fact Sheet for Recipients and Caregivers (8/2022)
- CDC/FDA COCA Call: Interim Clinical Considerations for Mpox Vaccination (slides, 8/2022)
- JYNNEOS Intradermal Administration Guidance (CDPH)
Other Vaccine Administration Resources
- JYNNEOS Preparation and Administration Summary for Subcutaneous Administration
- Subcutaneous Injection video (CDC)
- Injectable Vaccines by Route
- Preparing Liquid Vaccines
- Administering Injections
Vaccine Management and Reporting
- Mpox Ordering & Distribution Cadence Calendar (NEW!)
- Mpox Requirements at a Glance (Updated)
- JYNNEOS Storage & Handling Summary (CDC)
- Instructions for Flipping Off Cap for MVA-BN
- General Vaccine Storage and Handling job aids
- California Immunization Record:
Blank for Computer Print Out | Vaccines Listed to Fill Out by Hand - JYNNEOS Standing Orders for Subcutaneous Administration (CDC)
- JYNNEOS Standing Orders for Intradermal Administration (CDC)
- JYNNEOS Standing Orders template (Word) (CDPH, LA, SF)
Vaccine and Adverse Reactions Information
- JYNNEOS Vaccine Administration Errors and Deviations (CDC)
- JYNNEOS Contraindications & Precautions (CDC)
- List of Adverse Events after JYNNEOS Vaccination Requiring VAERS Reporting (CDC)
- Vaccine Adverse Event Reporting System (VAERS)
- Office Management of Anaphylaxis (CDPH)
- VAERS and VERP flyer (CDPH)
Mpox Disease Information and Educational Resources
- California Primary Care Association (CPCA) Mpox Webinar, 8/23/22 Slides and Recording
- Mpox webpage (CDPH)
- Mpox Q&A (CDPH)
- Mpox Communications Toolkit (CDPH)
- US Mpox Outbreak 2022: Situational Summary (CDC)
- Mpox CBO Partner Letter (HHS)
- Mpox Information for Healthcare Professionals (CDC)
- Interim Clinical Guidance for Treatment of Mpox (CDC)
- Mpox Clinician FAQs (CDC)
- Mpox Campaign Style Guide
- Coming Soon: Mpox Vaccines as Medi-Cal Benefits
- Mpox Services and Reimbursement for FQHC, RHC, IHS-MOA and Tribal FQHC Providers
- Orthopoxvirus and Mpox Coding & Guidance (AMA)
- HRSA Countermeasures Injury Compensation Program (CISP)
- Current Therapeutic Guidance on Mpox (IHS)
- Vaccine Resources for Healthcare Providers and People Living with HIV/AIDS